Aché sets strategy for growing in dermatology

With the ambitious goal of placing among the top three laboratories in dermatology of the country, Aché has restructured its business and put under the same umbrella dermomedicamentos and skin care. Today, the area represents 3% of its consolidated revenues, with sales of R$ 103 million in 2015. But that participation must grow in the coming years and achieve up to 15% in 2030.
"The goal is to be more representative and that will occur over the medium and long term," says the Director of Aché Derma, Monica white. This horizon, according to the Executive, it is also market dynamics of dermomedicamentos, whose development can take many years.
To grow in this market, the pharmacist will make use of innovation, expanding the partnership with medical grade and distribution of their products and, if there is opportunity, the procurement of products or companies. This last front, the process is still in the embryonic stage, but the Aché is already starting to look at alternatives. "We are mapping how we can evolve in acquisitions," he says.
The bet in Dermatology is embedded in the strategy that will sustain the new expansion cycle. The overall goal is to double the recipe every five years, starting in 2015. For 2016, at Aché Derma, the expectation is the 16% growth in revenue and release of eight products-three dermomedicamentos and five dermacosmetics.
The pace of new releases can make body over the next years, stimulated by the opening of the laboratory of Molecular Design and Synthesis of the lab. There, one of the highlights among the ongoing research is a new drug for the treatment of vitiligo, a disease that still defies the pharmaceutical industry.
Today, the Aché ''s portfolio has 21 dermacosmetics, distributed in eight categories and sold under the brand name Profuse, with turnover equivalent to 50% of sales of the seven dermomedicamentos of the laboratory. Cosmésticos market, says Monica, the leadership is in the hands of multinationals. In recent years, however, domestic enterprises, especially pharmaceutical, have accelerated the development of products.
Dermatology is now the fastest-growing specialty in medicine, according to Monica, and a growing audience has gotten on the radar of pharmaceuticals. One of the new trends in the area, the Executive cites the inclusion of increasingly elderly. "Another part of the population that deserves attention is adolescents, who have influence in the purchase."